Public-registry trials using Elacestrant that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer | Stemline Therapeutics, Inc. | Advanced Breast Cancer | PHASE1 | 42 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →